Search for: "DR. Reddy's Laboratories, Inc"
Results 61 - 80
of 102
Sorted by Relevance
|
Sort by Date
7 Feb 2018, 7:27 am
Reddy’s Laboratories, Inc. [read post]
16 Oct 2006, 7:58 pm
Reddy's settled their litigation over generic Imitrex, with the parties agreeing that Dr. [read post]
4 Jun 2019, 4:12 am
Reddy’s Laboratories Inc., the Federal Circuit reversed the district court and found the asserted patents invalid for failing to satisfy the written description requirement. [read post]
23 Dec 2009, 12:40 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Zyprexa (Olanzapine) – UK: Court of Appeal upholds Justice Floyd’s decision finding Olanzapine patent valid: Dr Reddy’s Laboratories v Eli Lilly (EPLAW) (IPKat) (Managing IP) (PatLit) (GenericsWeb) France: Pharma trade marks under threat - Senate and National Assembly approve law that… [read post]
2 Jan 2019, 2:15 am
How the likelihood of success on the merits should (or should not) be determined and the four factors balanced in a patent infringement case, are areas in which there has been significant disagreement among the judges of the Federal Circuit... [read post]
22 Apr 2014, 7:41 am
Reddy’s Laboratories, Ltd., 533 F.3d 1353 (Fed. [read post]
12 Oct 2010, 8:56 pm
Apotex asks Supreme Court to review generic Cozaar/Hyzaar 180-day exclusivity decision (FDA Law Blog) Faslodex (Fulvestrant) – US: AstraZeneca seeks review of BPAI decision concerning patent covering ‘Use of Fulvestrant in treatment of resistant breast cancer’ (Patent Docs) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against Dr Reddy’s following Para IV certification (Patent Docs) Lipitor (Atorvastatin) – US: Generic… [read post]
20 Jan 2021, 12:58 pm
Reddy’s Laboratories Inc., may not be relevant to any other case, but it caught my attention as an example of the perils of claim drafting. [read post]
17 Oct 2008, 1:32 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation… [read post]
23 Jun 2010, 10:28 pm
Reddy's over generic Allegra (Patent Docs) Combigan (Brimonidine) – US: Patent infringement complaint following a Para IV certification: Allergan, Inc. v. [read post]
18 May 2007, 1:23 am
Reddy's Laboratories Ltd. [read post]
3 Apr 2011, 10:21 pm
Reddy’s Laboratories, Inc’s June 2009 petition (Docket No. [read post]
28 Apr 2017, 9:56 am
Reddy’s Laboratories (UK) v. [read post]
29 Jun 2010, 6:01 pm
Reddy’s Laboratories, Ltd. et al. [read post]
30 Jun 2010, 5:52 am
Reddy's Laboratories, Ltd. et al. [read post]
16 Dec 2009, 3:39 am
Reddy's Laboratories Ltd. et al. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
27 Aug 2019, 2:03 am
Reddy’s Laboratories Inc., which seemed to impose a higher standard for satisfying the written description requirement, the Federal Circuit decision in Nalpropion Pharmaceuticals, Inc. v. [read post]
27 Dec 2021, 7:02 am
Prem Reddy, and California interventional cardiologist Dr. [read post]
3 Jun 2010, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law Blog) General Nature Biotechnology and more anti-gene patenting myths (Patent Docs) Alice de Pastor’s SPC news 2009 (The SPC Blog) US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law Blog) US: Blinded… [read post]
